Does epigenetics have a role in age related macular degeneration and diabetic retinopathy?

被引:11
作者
Devi, S. Mohana [1 ]
Mahalaxmi, I [2 ]
Kaavya, J. [2 ]
Chinnkulandhai, V [3 ]
Balachandar, V [4 ]
机构
[1] Sankara Nethralaya, SN ONGC Dept Genet & Mol Biol, Vis Res Fdn, 41-18 Coll Rd, Chennai 600006, Tamil Nadu, India
[2] Avinashilingam Univ Women, Avinashilingam Inst Home Sci & Higher Educ Women, Dept Zool, Coimbatore 641046, Tamil Nadu, India
[3] DrNGP Arts & Sci Coll, Dept Biochem, Coimbatore 641046, Tamil Nadu, India
[4] Bharathiar Univ, Dept Human Genet & Mol Biol, Human Mol Genet & Stem Cells Lab, Coimbatore 641046, Tamil Nadu, India
关键词
Age-related macular degeneration (AMD); Diabetic Retinopathy (DR); Epigenetics; Gene expression; MITOCHONDRIAL TRANSCRIPTION FACTOR; METABOLIC MEMORY; DNA METHYLATION; CONTINUED PROGRESSION; OXIDATIVE STRESS; IL17RC PROMOTER; POTENTIAL ROLE; COMPLICATIONS; MECHANISMS; HYPOMETHYLATION;
D O I
10.1016/j.gendis.2020.01.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epigenetic mechanisms play an important part in the regulation of gene expression and these alterations may induce long-term changes in gene function and metabolism. They have received extensive attention in bridging the gap between environmental exposures and disease development via their influence on gene expression. DNA methylation is the earliest discovered epigenetic alteration. In this review, we try to examine the role of DNA methylation and histone modification in Age related macular degeneration (AMD) and Diabetic Retinopathy (DR), its vascular complications and recent progress. Given the complex nature of AMD and DR, it is crucial to improve therapeutics which will greatly enhance the quality of life and reduce the burden for millions of patients living with these potentially blinding conditions. Copyright (C) 2020, Chongqing Medical University. Production and hosting by Elsevier B.V.
引用
收藏
页码:279 / 286
页数:8
相关论文
共 64 条
  • [1] Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy
    Agardh, Elisabet
    Lundstig, Annika
    Perfilyev, Alexander
    Volkov, Petr
    Freiburghaus, Tove
    Lindholm, Eero
    Ronn, Tina
    Agardh, Carl-David
    Ling, Charlotte
    [J]. BMC MEDICINE, 2015, 13
  • [2] The mammalian epigenome
    Bernstein, Bradley E.
    Meissner, Alexander
    Lander, Eric S.
    [J]. CELL, 2007, 128 (04) : 669 - 681
  • [3] Developing Cellular Therapies for Retinal Degenerative Diseases
    Bharti, Kapil
    Rao, Mahendra
    Hull, Sara Chandros
    Stroncek, David
    Brooks, Brian P.
    Feigal, Ellen
    van Meurs, Jan C.
    Huang, Christene A.
    Miller, Sheldon S.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (02) : 1191 - 1201
  • [4] Hyperglycemia and Vascular Metabolic Memory: Truth or Fiction?
    Bianchi, Cristina
    Miccoli, Roberto
    Del Prato, Stefano
    [J]. CURRENT DIABETES REPORTS, 2013, 13 (03) : 403 - 410
  • [5] DNA methylation patterns and epigenetic memory
    Bird, A
    [J]. GENES & DEVELOPMENT, 2002, 16 (01) : 6 - 21
  • [6] AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: A "glycoxidation-centric" point of view
    Chilelli, N. C.
    Burlina, S.
    Lapolla, A.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2013, 23 (10) : 913 - 919
  • [7] Elmasry Khaled, 2018, Oncotarget, V9, P12562, DOI 10.18632/oncotarget.24333
  • [8] Nuclear architecture and gene regulation
    Fedorova, Elena
    Zink, Daniele
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2008, 1783 (11): : 2174 - 2184
  • [9] Phenotypic plasticity and the epigenetics of human disease
    Feinberg, Andrew P.
    [J]. NATURE, 2007, 447 (7143) : 433 - 440
  • [10] Diabetic retinopathy
    Frank, RN
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (01) : 48 - 58